Intellipharmaceutics International Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

RIM Global - CC Bioscience

16,570

0.04%

0.03%

06/30/2017

Fidelity Nasdaq Composite Index

13,756

0.03%

07/31/2018

View Profile

Address	30 Worcester Road Toronto Ontario M9W 5X2 Canada
Employees	-
Website	http://www.intellipharmaceutics.com
Updated	09/14/2018
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi on October 22, 2009 and is headquartered in Toronto, Canada.